EQUILLIUM, INC.

Insiders Equillium, Inc.

Equities

EQ

US29446K1060

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-07 pm EDT			5-day change	1st Jan Change
1.78 ^USD	+3.49%		+19.46%	+146.20%

Apr. 02	H.C. Wainwright Adjusts Price Target on Equillium to $5 From $4, Keeps Buy Rating	MT
Apr. 01	Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1B Equalise Study of Itolizumab in Lupus Nephritis	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Equillium, Inc. Promotes Maple Fung to the Position of Chief Medical Officer	23-08-09	CI
Equillium, Inc. Appoints Preston Klassen Board of Directors	22-09-06	CI
Equillium, Inc. Appoints Barbara Troupin to its Board of Directors and as Member of Nominating and Corporate Governance Committee	22-03-01	CI
Equillium Acquires Biotechnology Company Bioniz Therapeutics	22-02-16	MT
Equillium, Inc. Announces Cessation of Dolca Thomas as Executive Vice President of Research & Development and Chief Medical Officer	22-02-16	CI
Equillium, Inc. Appoints Yu Xu, Ph.D., as A Class II Director	21-02-04	CI
Equillium, Inc. Appoints Dolca Thomas as Executive Vice President of Research & Development and Chief Medical Officer, Effective January 11, 2021	20-12-21	CI
Equillium, Inc. Announces Executive Changes	20-09-28	CI
Equillium, Inc. Announces Executive Changes	20-05-13	CI
Equillium, Inc. Announces Executive Changes	19-11-12	CI
Equillium Expands Scientific and Clinical Advisory Team	19-05-06	CI
Equillium, Inc. Announces Executive Appointments	18-11-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW